FIELD: medicine.
SUBSTANCE: inventions concern a vaccine and a method for using it. The characterised vaccine contains: (i) a live attenuated QX-like infectious bronchitis (IB) virus produced by egg passage with developing embryos from 25 to 80 times and having S1 protein coded by a nucleotide sequence which is min 95% identical to SEQ ID NO. 1; and (ii) a pharmaceutically acceptable carrier. A method for poultry protection against the QX-like infectious bronchitis (IB) virus involves administering the above vaccine into the poultry within the range of 103 TCID50 to 105,07 TCID50 per the above poultry.
EFFECT: presented inventions are applicable for protection against infectious bronchitis caused by IB-QX-like viruses.
12 cl, 18 tbl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
VACCINE FOR PROPHYLAXIS OF CHICKEN BURSA INFECTIOUS SICKNESS, LYOPHILIZED VIRAL COMPOSITION, METHOD OF CHICKEN PROTECTION FROM THIS DISEASE AND A METHOD OF LIVE VACCINE PREPARING | 1993 |
|
RU2126268C1 |
RECOMBINANT NONPATHOGENIC MDV VECTOR PROVIDING POLY-SPECIFIC IMMUNITY | 2012 |
|
RU2593950C2 |
STRAIN "O" OF VIRUS OF POULTRY INFECTIOUS LARYNGOTRACHEITIS FOR PREPARING DIAGNOSTIC AND VACCINE PREPARATIONS | 2002 |
|
RU2207372C1 |
RECOMBINANT HVT VECTORS EXPRESSING BIRD PATHOGENS ANTIGENS AND THEIR APPLICATION | 2012 |
|
RU2620936C2 |
VACCINE AGAINST INFECTIOUS BRONCHITIS | 2017 |
|
RU2781143C2 |
VACCINES BASED ON REOVIRUSES | 2015 |
|
RU2708316C2 |
VIRUS VACCINE AGAINST INFECTIOUS LARYNGOTRACHEITIS IN POULTRY | 2002 |
|
RU2214277C1 |
METHOD FOR MANUFACTURING VACCINE AGAINST INFECTIOUS LARYNGOTRACHEITIS IN POULTRY | 2003 |
|
RU2246317C1 |
RECOMBINANT MAREK'S DISEASE VIRUSES AND USES THEREOF | 2014 |
|
RU2681889C2 |
VACCINES BASED ON REOVIRUS | 2015 |
|
RU2724497C2 |
Authors
Dates
2015-11-10—Published
2009-08-07—Filed